A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Seattle Children's Hospital
Seattle Children's Hospital
Medical College of Wisconsin
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Barbara Ann Karmanos Cancer Institute
Emory University
Emory University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
NYU Langone Health
Memorial Sloan Kettering Cancer Center
Laboratorio Elea Phoenix S.A.
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Neotropix
Pediatric Brain Tumor Consortium